4.5 Article

Disrupted thalamocortical connectivity in PSP: A resting-state MARI, DTI, and VBM study

Journal

PARKINSONISM & RELATED DISORDERS
Volume 17, Issue 8, Pages 599-605

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2011.05.013

Keywords

Resting-state fMRI; Functional connectivity; White matter tracts; Atrophy; Dentatorubrothalamic tract

Funding

  1. Dana Foundation
  2. National Institutes of Health [R01-DC010367, R01-AG037491, R21-AG38736, R01-AG11378]
  3. Mayo Foundation

Ask authors/readers for more resources

Progressive supranuclear palsy (PSP) is associated with pathological changes along the dentatorubrothalamic tract and in premotor cortex. We aimed to assess whether functional neural connectivity is disrupted along this pathway in PSP, and to determine how functional changes relate to changes in structure and diffusion. Eighteen probable PSP subjects and 18 controls had resting-state (task-free) fMRI, diffusion tensor imaging and structural MRI. Functional connectivity was assessed between thalamus and the rest of the brain, and within the basal ganglia, salience and default mode networks (DMN). Patterns of atrophy were assessed using voxel-based morphometry, and patterns of white matter tract degeneration were assessed using tract-based spatial statistics. Reduced in-phase functional connectivity was observed between the thalamus and premotor cortex including supplemental motor area (SMA), striatum, thalamus and cerebellum in PSP. Reduced connectivity in premotor cortex, striatum and thalamus were observed in the basal ganglia network and DMN, with subcortical salience network reductions. Tract degeneration was observed between cerebellum and thalamus and in superior longitudinal fasciculus, with grey matter loss in frontal lobe, premotor cortex, SMA and caudate nucleus. SMA functional connectivity correlated with SMA volume and measures of cognitive and motor dysfunction, while thalamic connectivity correlated with degeneration of superior cerebellar peduncles. PSP is therefore associated with disrupted thalamocortical connectivity that is associated with degeneration of the dentatorubrothalamic tract and the presence of cortical atrophy. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

Neha Atulkumar Singh, Nirubol Tosakulwong, Jonathan Graff-Radford, Mary M. Machulda, Nha Trang Thu Pham, Irene Sintini, Stephen D. Weigand, Christopher G. Schwarz, Matthew L. Senjem, Minerva M. Carrasquillo, Nilufer Ertekin-Taner, Clifford R. Jack, Val J. Lowe, Keith A. Josephs, Jennifer L. Whitwell

Summary: APOE epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), but its influence in atypical presentations of AD is not well-known. This study found that APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau deposition, while non-carriers showed faster rates of atrophy and tau accumulation in certain brain regions.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Association of neighborhood socioeconomic disadvantage and cognitive impairment

Maria Vassilaki, Jeremiah A. Aakre, Anna Castillo, Alanna M. Chamberlain, Patrick M. Wilson, Walter K. Kremers, Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, Rabe E. Alhurani, Jonathan Graff-Radford, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack, David S. Knopman, Ronald C. Petersen

Summary: The study found an association between neighborhood socioeconomic deprivation and cognitive decline, mild cognitive impairment, and dementia in older adults. Higher levels of neighborhood deprivation were associated with an increased risk of progression to dementia and slightly faster cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers

Michael W. Weiner, Danielle Harvey, Susan M. Landau, Dallas P. Veitch, Thomas C. Neylan, Jordan H. Grafman, Paul S. Aisen, Ronald C. Petersen, Clifford R. Jack, Duygu Tosun, Leslie M. Shaw, John Q. Trojanowski, Andrew J. Saykin, Jacqueline Hayes, Charles De Carli

Summary: The study found no significant association between TBI and/or PTSD and biomarker-defined AD. Veterans with TBI and/or PTSD had poorer cognitive status, which may be attributed to other comorbid pathologies.

ALZHEIMERS & DEMENTIA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus

Emanuele Camerucci, Jonathan Graff-Radford, David T. Jones, Benjamin D. Elder, Jeffrey L. Gunter, Jeremy K. Cutsforth-Gregory, Hugo Botha, Matthew C. Murphy, Derek R. Johnson, Caroline Davidge-Pitts, Clifford R. Jack, John Huston, Petrice M. Cogswell

Summary: This study evaluated the change in size of focally enlarged sulci (FES) and pituitary height after shunt placement in patients with idiopathic normal pressure hydrocephalus (iNPH). The results showed a significant decrease in FES volume and a significant increase in pituitary gland size after shunt placement.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Oncology

Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration

Firat Kara, Christine M. Lohse, Anna M. Castillo, Nirubol Tosakulwong, Timothy G. Lesnick, Clifford R. Jack, Ronald C. Petersen, Janet E. Olson, Fergus J. Couch, Kathryn J. Ruddy, Kejal Kantarci, Michelle M. Mielke

Summary: This study aimed to investigate whether the use of selective estrogen receptor modifiers (SERMs), including tamoxifen and raloxifene, was associated with cognitive performance and markers of neurodegeneration associated with Alzheimer's disease. The results showed no significant associations between the use of SERMs and cognition or MCI in both breast cancer patients and women without a history of cancer.

CANCER MEDICINE (2023)

Article Neurosciences

Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease

Nick Corriveau-Lecavalier, Leland R. Barnard, Jeyeon Lee, Ellen Dicks, Hugo Botha, Jonathan Graff-Radford, Mary M. Machulda, Bradley F. Boeve, David S. Knopman, Val J. Lowe, Ronald C. Petersen, Clifford R. Jack, David T. Jones

Summary: This study reveals the heterogeneity of dysexecutive Alzheimer's disease (dAD) and proposes a conceptual framework of executive components based on clinico-radiological associations. The use of data-driven approaches can provide valuable insights into brain-behavior relationships in dAD.

CEREBRAL CORTEX (2023)

Article Clinical Neurology

Predicting amyloid PET and tau PET stages with plasma biomarkers

Clifford R. Jack Jr, Heather J. Wiste, Alicia Algeciras-Schimnich, Dan J. Figdore, Christopher G. Schwarz, Val J. Lowe, Vijay K. Ramanan, Prashanthi Vemuri, Michelle M. Mielke, David S. Knopman, Jonathan Graff-Radford, Bradley F. Boeve, Kejal Kantarci, Petrice M. Cogswell, Matthew L. Senjem, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen

Summary: Staging the severity of Alzheimer's disease pathology is important for therapeutic trials and clinical prognosis. Biomarkers such as amyloid and tau PET can be used for disease staging, but plasma biomarkers would be more practical.

BRAIN (2023)

Article Clinical Neurology

Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis

Vijay K. Ramanan, Robel K. Gebre, Jonathan Graff-Radford, Ekaterina Hofrenning, Alicia Algeciras-Schimnich, Daniel J. Figdore, Val J. Lowe, Michelle M. Mielke, David S. Knopman, Owen A. Ross, Clifford R. Jack Jr, Ronald C. Petersen, Prashanthi Vemuri

Summary: Ramanan et al. found that integrating genetic risk scores improves the diagnostic value of plasma biomarkers for Alzheimer's disease, especially in predicting amyloid PET positivity. However, more advances are needed before these biomarkers can be widely used. By analyzing a large sample, they discovered that the AD-GRS is independently associated with amyloid PET levels and significantly enhances the classification accuracy of amyloid PET positivity when combined with high plasma p-tau(181). Machine learning methods that incorporate plasma biomarkers, demographics, and the AD-GRS show high accuracy in predicting amyloid PET levels.

BRAIN (2023)

Article Clinical Neurology

Altered within- and between-network functional connectivity in atypical Alzheimer's disease

Neha Atulkumar Singh, Peter R. Martin, Jonathan Graff-Radford, Irene Sintini, Mary M. Machulda, Joseph R. Duffy, Jeffrey L. Gunter, Hugo Botha, David T. Jones, Val J. Lowe, Clifford R. JackJr, Keith A. Josephs, Jennifer L. Whitwell

Summary: Posterior cortical atrophy and logopenic progressive aphasia are atypical clinical presentations of Alzheimer's disease, both showing disruptions in functional networks. The language network is affected in logopenic progressive aphasia, while the visual network is affected in posterior cortical atrophy. However, there is limited knowledge about the differences in connectivity within and between brain networks in these atypical Alzheimer's disease phenotypes.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease

Nick Corriveau-Lecavalier, Jeffrey L. Gunter, Michael Kamykowski, Ellen Dicks, Hugo Botha, Walter K. Kremers, Jonathan Graff-Radford, Daniela A. Wiepert, Christopher G. Schwarz, Essa Yacoub, David S. Knopman, Bradley F. Boeve, Kamil Ugurbil, Ronald C. Petersen, Clifford R. Jack, Melissa J. Terpstra, David T. Jones

Summary: From a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Age-related disruption of the default mode network is accelerated by amyloid deposition in all syndromic presentations of Alzheimer's disease, while syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. This study investigates the use of a biomarker of default mode network dysfunction, the network failure quotient, to assess Alzheimer's disease in a normative cohort and differentiate between different phenotypes of the disease. The study provides important insights into the shared pathophysiological mechanisms and distinct neurodegenerative processes involved in Alzheimer's disease.

BRAIN COMMUNICATIONS (2023)

Article Neurosciences

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)

Nicole S. McKay, Brian A. Gordon, Russ C. Hornbeck, Aylin Dincer, Shaney Flores, Sarah J. Keefe, Nelly Joseph-Mathurin, Clifford R. Jack, Robert Koeppe, Peter R. Millar, Beau M. Ances, Charles D. Chen, Alisha Daniels, Diana A. Hobbs, Kelley Jackson, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Michael L. Nickels, Farzaneh Rahmani, Laura Swisher, Qing Wang, Ricardo F. Allegri, Sarah B. Berman, Adam M. Brickman, William S. Brooks, David M. Cash, Jasmeer P. Chhatwal, Gregory S. Day, Martin R. Farlow, Christian la Fougere, Nick C. Fox, Michael Fulham, Bernardino Ghetti, Neill Graff-Radford, Takeshi Ikeuchi, William Klunk, Jae-Hong Lee, Johannes Levin, Ralph Martins, Colin L. Masters, Jonathan McConathy, Hiroshi Mori, James Noble, Gerald Reischl, Christopher Rowe, Stephen Salloway, Raquel Sanchez-Valle, Peter R. Schofield, Hiroyuki Shimada, Mikio Shoji, Yi Su, Kazushi Suzuki, Jonathan Voeglein, Igor Yakushev, Carlos Cruchaga, Jason Hassenstab, Celeste Karch, Eric McDade, Richard J. Perrin, Chengjie Xiong, John C. Morris, Randall J. Bateman, Tammie L. S. Benzinger

Summary: The Dominantly Inherited Alzheimer Network (DIAN) is an international collaboration that studies autosomal dominant Alzheimer disease (ADAD). ADAD arises from mutations in three genes. Non-carrier siblings from ADAD families can be recruited for case-control studies. The predictable age of onset in ADAD allows for mapping candidate AD biomarkers during the preclinical phase. This study provides valuable data for understanding early disease stages of both ADAD and sporadic AD, as well as for research in healthy aging.

NATURE NEUROSCIENCE (2023)

Review Neurosciences

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Jacob W. Vogel, Nick Corriveau-Lecavalier, Nicolai Franzmeier, Joana B. Pereira, Jesse A. Brown, Anne Maass, Hugo Botha, William W. Seeley, Dani S. Bassett, David T. Jones, Michael Ewers

Summary: Neurodegenerative diseases are the main cause of dementia, and recent findings suggest that pathological proteins spread through brain networks. The alterations in brain networks may actively modulate the spreading of these proteins. Understanding these mechanisms is crucial for predicting and treating neurodegenerative diseases.

NATURE REVIEWS NEUROSCIENCE (2023)

Article Clinical Neurology

The semicircular canal function is preserved with little impact on falls in patients with mild Parkinson's disease

Jun-Pyo Hong, Hanim Kwon, Euyhyun Park, Sun-Uk Lee, Chan-Nyoung Lee, Byung-Jo Kim, Ji-Soo Kim, Kun-Woo Park

Summary: In patients with mild-to-moderate PD, vestibular function assessed by video head-impulse tests appears relatively preserved and has minimal impact on the risk of falls. Risk of postural instability is associated with the severity of clinical symptoms in PD.

PARKINSONISM & RELATED DISORDERS (2024)

Article Clinical Neurology

Estimating the sequence of biomarker changes in Parkinson's disease

Yaqin Xiang, XiuRong Huang, Qian Xu, Zhenhua Liu, Yase Chen, Qiying Sun, Junling Wang, Hong Jiang, Lu Shen, Xinxiang Yan, Beisha Tang, Jifeng Guo

Summary: Using the novel data-driven method DEBM, this study determined the sequence of several common biomarker changes in Parkinson's disease (PD). The left putamen was found to be the earliest biomarker to become abnormal, followed by the right putamen, CSF alpha-synuclein, right caudate, left caudate, and serum NfL. The estimated disease stages showed significant differences between PD and healthy controls, and achieved a high accuracy for distinguishing PD from HC.

PARKINSONISM & RELATED DISORDERS (2024)

Article Clinical Neurology

Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism

Yan Li, David J. McLernon, Carl E. Counsell, Angus D. Macleod

Summary: This study aimed to investigate the incidence and risk factors for institutionalisation in Parkinson's disease (PD) and atypical parkinsonism (AP). The study found that institutionalisation was more frequent in AP compared to PD and controls. Age, poorer cognition, and more-severe parkinsonian impairment were independent predictors of institutionalisation.

PARKINSONISM & RELATED DISORDERS (2024)